Overview
Status
Active
Registry date
2006-11-16
Registered address
ul. Chopina 16, 34-700 Rabka-Zdrój, Poland
Electronic delivery address
AE:PL-10770-75738-DVBDU-23
Financials
Filing timeliness
1 of 1 financial statements was filed late (for 2025, 69 days late).
- 202522/09/2026
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Sector · Wholesale and retail trade; repair of motor vehicles including motorcycles15,699 / 29,903
Top 53%
Results vs industry
Revenue
This companyUSD 799.42kMedianUSD 1.92mAverageUSD 5.20m
Net profit
This companyUSD -121.60kMedianUSD 20.70kAverageUSD 86.70k
Operating costs
This companyUSD 919.43kMedianUSD 1.88mAverageUSD 5.04m
Assets
This companyUSD 198.14kMedianUSD 543.65kAverageUSD 1.76m
Industry
National Health Fund (NFZ) contracts
M. Garus has been an NFZ healthcare provider since 2023. In 2026 it is performing 4 contracts with a total value of USD 0.00. All its contracts were worth USD 3.41k in total.
NFZ contract value by year (USD)
| Type of care | NFZ branch | Contracts | Value in 2026 |
|---|---|---|---|
| Provision of medical devices | małopolskie | 1 | USD 0.00 |
| Pilot programmes | opolskie | 1 | USD 0.00 |
| Other services provided in pharmacies | opolskie | 1 | USD 0.00 |
| Other services provided in pharmacies | małopolskie | 1 | USD 0.00 |
Ownership
| Owner |
|---|
Monika Garusage 47 |
Dorota Obajtekage 50 |
Manner of representation
Each partner may represent the company independently.
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2006-12-01.
49 1020 3466 0000 9102 0220 7041
86 1140 1078 0000 7141 4800 1004
62 1020 3466 0000 9102 0137 0667
Debt
No entries in the National Debtors Register (KRZ).
Public aid
5 public aid cases recorded, with a total value of $22,599.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Sep 20, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | –– | Prezes Zakładu Ubezpieczeń Społecznych | |
| Jul 17, 2020 | Other crisis aid | –– | Starosta Powiatu Nowy Targ | |
| May 30, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | –– | Prezes Zakładu Ubezpieczeń Społecznych |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| DR ZdrowieS.A. | $43,934,650.47 | drzdrowie.pl | ||
| Dolnośląska Grupa AptecznaS.A. | $30,168,188.68 | dgasa.pl | ||
| Cefarm RzeszówS.A. | $28,356,418.72 | cefarmrzeszow.pl | ||
| Apis Farmacjasp. z o.o. | $14,614,704.02 | apisapteka.pl | ||
| Farmjugsp. z o.o. | $14,506,326.49 | farmjug.pl | ||
| Fragalsp. z o.o. | $5,374,285.81 | aptekafragal.pl | ||
| Adpharmasp. z o.o. | $5,595,917.60 | adamed.com | ||
| Farmjug Agsp. z o.o. | $4,213,734.86 | farmjug.pl | ||
| Alfa Pharm - Małgorzata Janusik, Jarosław Janusiksp. j. | $3,414,382.70 | aptekazielona.com.pl | ||
| Eurekasp. z o.o. | $1,377,733.77 | fundacja-eureka.edu.pl |
Change history
| Date | Event | |
|---|---|---|
| 2025-06-09 | Address change (Chopina, Dom Handlowy Gazda Steskal 16, 34-700, Rabka-Zdrój → Ul. Chopina 16, 34-700, Rabka-Zdrój) | |
| 2025-06-09 | Name change (Apteka Małgorzata Palarczyk, Marcin Palarczyk → M. Garus) | |
| 2025-06-09 | PKD change (Added: 47.27.Z) | |
| 2009-12-23 | Switch to PKD 2007 (3 PKD 2004 codes → 3 PKD 2007 codes) | |
| 2006-11-16 | Entered in the register |
FAQ
The main business activity of M. Garus focuses on dispensing chemist in specialised stores.
The company was registered in the Polish National Court Register (KRS) on November 16, 2006.
The headquarters is located at: ul. Chopina 16, 34-700 Rabka-Zdrój.
The legal form of this entity is a general partnership (sp.j.).
The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.
In 2025, the company generated total revenue of USD 799,425.
No, in 2025 the company was not profitable, reporting a net loss of USD 121,604.
The largest operating cost category falls under cost of goods and materials sold. This category amounted to USD 632,469 in 2025, representing 69% of all operating expenses.
Last updated: 2026-09-22